The following group helps Connor Cures determine where to invest the money we raise into the best possible trials and research.Jeff Knipstein, MD, Division of Oncology, Children’s National Medical Center
Dr. Knipstein is a pediatric oncologist in the Division of Oncology at Children’s National Medical Center and the Center for Cancer and Blood Disorders of Northern Virginia. He received his medical degree from Washington University in St. Louis and completed his pediatrics residency at the University of Michigan/C.S. Mott Children’s Hospital. During his hematology/oncology and neuro-oncology fellowships at the University of Colorado/Children’s Hospital Colorado, he studied novel drug therapies for Atypical Teratoid/Rhabdoid Tumors
. He specializes in the treatment of children with tumors of the central nervous system.Sherri Rose, PhD, Harvard Medical School
Dr. Rose is an Assistant Professor of Biostatistics in the Department of Health Care Policy at Harvard Medical School. Broadly, Dr. Rose’s research focuses on statistical methodology for health care and public health, including the study of rare diseases such as cancer. This work incorporates new approaches to more effectively identify risk factors, as well as optimal treatments. In 2011, Dr. Rose coauthored the book “Targeted Learning: Causal Inference for Observational and Experimental Data” for the Springer Series in Statistics. She received her Ph.D. in Biostatistics from the University of California, Berkeley, where she was awarded the Evelyn Fix Memorial Medal, and was previously a National Science Foundation fellow at Johns Hopkins Bloomberg School of Public Health in the Department of Biostatistics.